# FDA Inspection 1221394 - TriForLife, LLC - September 11, 2023

Source: https://www.keypedia.com/records/fda_inspections/triforlife-llc/37c76948-aa36-4b2a-b082-21afe96895a6
Source feed: FDA_Inspections

> FDA Inspection 1221394 for TriForLife, LLC on September 11, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1221394
- Company Name: TriForLife, LLC
- Inspection Date: 2023-09-11
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1303042 - 2026-01-16](https://www.keypedia.com/records/fda_inspections/triforlife-llc/e33dc121-d19a-41b1-b202-594503cb4c54)
- [FDA Inspection 1303042 - 2026-01-16](https://www.keypedia.com/records/fda_inspections/triforlife-llc/583d79f3-0ec7-40c9-9c3a-5258154d881a)

Company: https://www.keypedia.com/companies/triforlife-llc/00b57271-f28c-4d9e-b0e4-9b40d9b9777f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d